MUMBAI, India, June 19 -- Intellectual Property India has published a patent application (202617055708 A) filed by Vertex Pharmaceuticals Incorporated on May 01, 2026, for Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator.
Inventors include Abela, Alexander Russell; Clemens, Jeremy; Hadida Ruah, Sara Sabina; Cleveland, Thomas; Cook, Christopher Dean; Coon, Timothy Richard; Dinh, Andrew Nguyen; Pierre, Fabrice; Khatuya, Haripada; Leon Mostajo, Brian; Miller, Mark Thomas; Motevalli, Somayeh; Nano, Adela; Ursu, Oleg; Uy, Johnny; and Zhou, Jinglan.
The application for the patent was published on June 05, 2026, under issue no. 23/2026.
Abstract: This disclosure provides modulators of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR), pharmaceutical compositions containing at least one such modulator, methods of treatment of CFTR mediated diseases, including cystic fibrosis, using such modulators and pharmaceutical compositions, combination pharmaceutical compositions and combination therapies employing those modulators, and processes and intermediates for making such modulators.
Disclaimer: Curated by HT Syndication.
